Medicamen Organics Limited — Updates, 03-01-2025: Press Release

Medicamen Organics Limited has completed the incorporation of Grande Etoile Pharmaceuticals Limited (GEPL), a subsidiary aimed at expanding its presence in the Pharmaceuticals, Healthcare, and Cosmetics sectors. With an initial authorized capital of ₹1 Cr and a paid-up share capital of ₹50 Lakh, Medicamen holds a 50.92% stake in GEPL. The subsidiary will focus on the distribution and export of a wide range of products, including medicines, antibiotics, vaccines, and dietary supplements. This move aligns with Medicamen's strategic goals to diversify its portfolio and enhance its distribution network, positioning the company for significant growth opportunities in the evolving healthcare market. MD Mr. Bal Kishan Gupta emphasized that this initiative will strengthen the company's role in addressing the increasing demand for high-quality healthcare products globally. This development signals a positive outlook for prospective growth and revenue potential for Medicamen Organics in the coming years.